• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巴基斯坦丙型肝炎病毒基因型:系统综述。

Hepatitis C virus genotypes in Pakistan: a systemic review.

机构信息

Department of Zoology, Islamia College (Public Sector University) Peshawar, Khyber Pakhtunkhwa, Pakistan.

出版信息

Virol J. 2011 Sep 8;8:433. doi: 10.1186/1743-422X-8-433.

DOI:10.1186/1743-422X-8-433
PMID:21902822
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3178528/
Abstract

BACKGROUND AND AIM

Phylogenetic analysis has led to the classification of hepatitis C virus (HCV) into 1-6 major genotypes. HCV genotypes have different biological properties, clinical outcome and response to antiviral treatment and provide important clues for studying the epidemiology, transmission and pathogenesis. This article deepens the current molecular information about the geographical distribution of HCV genotypes and subgenotypes in population of four provinces of Pakistan. 34 published papers (1996-2011) related to prevalence of HCV genotypes/serotypes and subgenotypes in Pakistan were searched.

RESULT

HCV genotype/s distribution from all 34 studies was observed in 28,400 HCV infected individuals in the following pattern: 1,999 (7.03%) cases of genotype 1; 1,085 (3.81%) cases of genotype 2; 22,429 (78.96%) cases of genotype 3; 453 (1.59%) cases of genotype 4; 29 (0.10%) cases of genotype 5; 37 (0.13%) cases of genotype 6; 1,429 (5.03%) cases of mixed genotypes, and 939 (3.30%) cases of untypeable genotypes. Overall, genotype 3a was the predominant genotype with a rate of 55.10%, followed by genotype 1a, 3b and mixed genotype with a rate of 10.25%, 8.20%, and 5.08%, respectively; and genotypes 4, 5 and 6 were rare. Genotype 3 occurred predominately in all the provinces of Pakistan. Second more frequently genotype was genotype 1 in Punjab province and untypeable genotypes in Sindh, Khyber Pakhtunkhwa and Balochistan provinces.

摘要

背景与目的

系统发生分析将丙型肝炎病毒(HCV)分为 1-6 种主要基因型。HCV 基因型具有不同的生物学特性、临床结局和抗病毒治疗反应,为研究其流行病学、传播和发病机制提供了重要线索。本文深入探讨了目前关于巴基斯坦四个省份 HCV 基因型和亚型在人群中的地理分布的分子信息。检索了 34 篇(1996-2011 年)与巴基斯坦 HCV 基因型/血清型流行情况相关的已发表文献。

结果

在对所有 34 项研究中,在 28400 例 HCV 感染个体中观察到 HCV 基因型/亚型分布情况如下:1 型 999 例(7.03%);2 型 1085 例(3.81%);3 型 22429 例(78.96%);4 型 453 例(1.59%);5 型 29 例(0.10%);6 型 37 例(0.13%);混合基因型 1429 例(5.03%);未定型基因型 939 例(3.30%)。总体而言,基因型 3a 是最主要的基因型,占 55.10%,其次是基因型 1a、3b 和混合基因型,分别占 10.25%、8.20%和 5.08%;基因型 4、5 和 6 则较为少见。基因型 3 在巴基斯坦所有省份均占主导地位。其次,旁遮普省以基因型 1 为主,信德省、开伯尔-普赫图赫瓦省和俾路支省以未定型基因型为主。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c66/3178528/9b40cc782d7f/1743-422X-8-433-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c66/3178528/cac77bd42132/1743-422X-8-433-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c66/3178528/9b40cc782d7f/1743-422X-8-433-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c66/3178528/cac77bd42132/1743-422X-8-433-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c66/3178528/9b40cc782d7f/1743-422X-8-433-2.jpg

相似文献

1
Hepatitis C virus genotypes in Pakistan: a systemic review.巴基斯坦丙型肝炎病毒基因型:系统综述。
Virol J. 2011 Sep 8;8:433. doi: 10.1186/1743-422X-8-433.
2
Hepatitis C virus prevalence and genotype distribution in Pakistan: Comprehensive review of recent data.巴基斯坦丙型肝炎病毒流行率及基因型分布:近期数据的综合综述
World J Gastroenterol. 2016 Jan 28;22(4):1684-700. doi: 10.3748/wjg.v22.i4.1684.
3
NIH Consensus Statement on Management of Hepatitis C: 2002.美国国立卫生研究院关于丙型肝炎管理的共识声明:2002年。
NIH Consens State Sci Statements. 2002;19(3):1-46.
4
Peginterferon alfa and ribavirin for chronic hepatitis C in patients eligible for shortened treatment, re-treatment or in HCV/HIV co-infection: a systematic review and economic evaluation.聚乙二醇干扰素 α 和利巴韦林治疗适合缩短疗程、再治疗或合并 HCV/HIV 感染的慢性丙型肝炎患者:系统评价和经济评估。
Health Technol Assess. 2011 Apr;15(17):i-xii, 1-210. doi: 10.3310/hta15170.
5
Direct-acting antivirals for chronic hepatitis C.用于慢性丙型肝炎的直接作用抗病毒药物。
Cochrane Database Syst Rev. 2017 Sep 18;9(9):CD012143. doi: 10.1002/14651858.CD012143.pub3.
6
Direct-acting antivirals for chronic hepatitis C.用于慢性丙型肝炎的直接作用抗病毒药物。
Cochrane Database Syst Rev. 2017 Jun 6;6(6):CD012143. doi: 10.1002/14651858.CD012143.pub2.
7
Systematic review: epidemiology of hepatitis C genotype 6 and its management.系统评价:丙型肝炎病毒基因型 6 的流行病学及其管理。
Aliment Pharmacol Ther. 2011 Aug;34(3):286-96. doi: 10.1111/j.1365-2036.2011.04714.x. Epub 2011 May 29.
8
Hepatitis C virus in Pakistan: a systematic review of prevalence, genotypes and risk factors.巴基斯坦丙型肝炎病毒:流行率、基因型和危险因素的系统评价。
World J Gastroenterol. 2009 Dec 7;15(45):5647-53. doi: 10.3748/wjg.15.5647.
9
Extended peginterferon plus ribavirin treatment for 72 weeks versus standard peginterferon plus ribavirin treatment for 48 weeks in chronic hepatitis C genotype 1 infected slow-responder adult patients.对于慢性丙型肝炎基因1型感染的低反应成年患者,长效聚乙二醇干扰素联合利巴韦林治疗72周与标准聚乙二醇干扰素联合利巴韦林治疗48周的对比研究。
Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD008516. doi: 10.1002/14651858.CD008516.pub2.
10
Epidemiological burden estimates for pathologies with a nonconstant risk: an application to HCV in Italy according to age, Metavir score, and genotype: A systematic review and meta-analysis.非恒定风险疾病的流行病学负担估计:根据年龄、梅塔维分级和基因型对意大利丙型肝炎病毒的应用:一项系统评价和荟萃分析
Medicine (Baltimore). 2016 Oct;95(42):e5143. doi: 10.1097/MD.0000000000005143.

引用本文的文献

1
Recent updates on molecular epidemiology of hepatitis C virus in Gujranwala, Pakistan.巴基斯坦古吉兰瓦拉丙型肝炎病毒分子流行病学的最新进展
Afr Health Sci. 2024 Dec;24(4):20-28. doi: 10.4314/ahs.v24i4.4.
2
Determination of hepatitis C virus subtype prevalent in Sindh, Pakistan: a phylogenetic analysis.巴基斯坦信德省丙型肝炎病毒流行亚型的确定:系统发育分析。
Sci Rep. 2024 May 15;14(1):11159. doi: 10.1038/s41598-024-59342-7.
3
Prevalence of Hepatitis C Virus Infection, Genotypes and Subtypes in Migrants from Pakistan in Barcelona, Spain.

本文引用的文献

1
Hepatitis C in Pakistan: a review of available data.巴基斯坦的丙型肝炎:现有数据综述
Hepat Mon. 2010 Summer;10(3):205-14. Epub 2010 Sep 1.
2
Share of Afghanistan populace in hepatitis B and hepatitis C infection's pool: is it worthwhile?阿富汗人口中乙肝和丙肝感染人群的比例:有必要吗?
Virol J. 2011 May 11;8:216. doi: 10.1186/1743-422X-8-216.
3
Frequency distribution of HCV genotypes among chronic hepatitis C patients of Khyber Pakhtunkhwa.在开伯尔-普赫图赫瓦省的慢性丙型肝炎患者中丙型肝炎基因型的频率分布。
西班牙巴塞罗那的巴基斯坦移民中丙型肝炎病毒感染、基因型和亚型的流行情况
Infect Drug Resist. 2022 Aug 18;15:4637-4644. doi: 10.2147/IDR.S367715. eCollection 2022.
4
Hepatitis C virus transmission cluster among injection drug users in Pakistan.巴基斯坦注射吸毒者中丙型肝炎病毒传播群。
PLoS One. 2022 Jul 15;17(7):e0270910. doi: 10.1371/journal.pone.0270910. eCollection 2022.
5
Detection, quantification and genotype distribution of HCV patients in Lahore, Pakistan by real-time PCR.采用实时 PCR 技术在巴基斯坦拉合尔检测、定量和分析 HCV 患者的基因型分布。
Afr Health Sci. 2020 Sep;20(3):1143-1152. doi: 10.4314/ahs.v20i3.16.
6
Molecular epidemiology of Hepatitis B virus, Hepatitis C virus, and Hepatitis D virus in general population of Afghanistan.阿富汗普通人群中乙型肝炎病毒、丙型肝炎病毒和丁型肝炎病毒的分子流行病学。
Turk J Gastroenterol. 2020 Sep;31(9):658-666. doi: 10.5152/tjg.2020.19169.
7
Validation of Novel Fibrosis Index (NFI) for assessment of liver fibrosis: comparison with transient elastography (FibroScan).用于评估肝纤维化的新型纤维化指数(NFI)的验证:与瞬时弹性成像(FibroScan)的比较。
BMJ Open Gastroenterol. 2019 Oct 18;6(1):e000316. doi: 10.1136/bmjgast-2019-000316. eCollection 2019.
8
Systematic overview of hepatitis C infection in the Middle East and North Africa.中东和北非地区丙型肝炎感染的系统综述。
World J Gastroenterol. 2018 Jul 21;24(27):3038-3054. doi: 10.3748/wjg.v24.i27.3038.
9
Role of Direct Antiviral Agents in Treatment of Chronic Hepatitis C Infection in Renal Transplant Recipients.直接抗病毒药物在肾移植受者慢性丙型肝炎感染治疗中的作用
J Transplant. 2018 Mar 28;2018:7579689. doi: 10.1155/2018/7579689. eCollection 2018.
10
Impact of Direct Acting Antiviral Therapy for Treatment of Hepatitis C Genotypes 1, 3 and 4: A Real Life Experience from India.直接作用抗病毒疗法治疗丙型肝炎基因1型、3型和4型的疗效:来自印度的真实病例经验
J Clin Exp Hepatol. 2018 Mar;8(1):7-14. doi: 10.1016/j.jceh.2017.06.003. Epub 2017 Jun 19.
Virol J. 2011 Apr 26;8:193. doi: 10.1186/1743-422X-8-193.
4
Seroprevalence of hepatitis B and C genotypes among young apparently healthy females of karachi-pakistan.巴基斯坦卡拉奇年轻健康女性中乙型肝炎和丙型肝炎基因型的血清流行率。
Libyan J Med. 2008 Jun 1;3(2):66-70. doi: 10.4176/071123.
5
Molecular epidemiology of hcv among health care workers of khyber pakhtunkhwa.在开伯尔-普赫图赫瓦省卫生保健工作者中的丙型肝炎病毒分子流行病学。
Virol J. 2011 Mar 8;8:105. doi: 10.1186/1743-422X-8-105.
6
Hepatitis C virus genotypes circulating in district Swat of Khyber Pakhtoonkhaw, Pakistan.巴基斯坦开伯尔-普赫图赫瓦省斯瓦特地区流行的丙型肝炎病毒基因型。
Virol J. 2011 Jan 14;8:16. doi: 10.1186/1743-422X-8-16.
7
Hepatitis C virus genotype 3a with phylogenetically distinct origin is circulating in Pakistan.起源在系统发育上不同的丙型肝炎病毒3a基因型正在巴基斯坦传播。
Genet Vaccines Ther. 2011 Jan 6;9(1):2. doi: 10.1186/1479-0556-9-2.
8
Occult hepatitis C virus infection and associated predictive factors: the Pakistan experience.隐匿性丙型肝炎病毒感染及相关预测因素:巴基斯坦经验。
Infect Genet Evol. 2011 Mar;11(2):442-5. doi: 10.1016/j.meegid.2010.12.004. Epub 2010 Dec 22.
9
Prevalence of hepatitis C virus (HCV) genotypes among positive UAE patients.阿联酋阳性患者中丙型肝炎病毒(HCV)基因型的流行情况。
Mol Biol Rep. 2011 Apr;38(4):2719-22. doi: 10.1007/s11033-010-0415-5. Epub 2010 Nov 20.
10
Molecular epidemiology of Hepatitis C virus genotypes in Khyber Pakhtoonkhaw of Pakistan.巴基斯坦开伯尔-普赫图赫瓦省丙型肝炎病毒基因型的分子流行病学。
Virol J. 2010 Aug 26;7:203. doi: 10.1186/1743-422X-7-203.